06:18 AM EDT, 04/28/2025 (MT Newswires) -- Revvity ( RVTY ) reported Q1 adjusted earnings Monday of $1.01 per diluted share, up from $0.98 a year earlier.

Analysts polled by FactSet expected $0.95.

Revenue for the quarter ended March 31 was $664.8 million, up from $649.9 million a year earlier.

Analysts surveyed by FactSet expected $661.0 million.

For 2025, the biopharmaceutical company maintained its adjusted EPS guidance of $4.90 to $5.00 while raising its revenue forecast to $2.83 billion to $2.87 billion, up from its previous projection of $2.80 billion to $2.85 billion.

Analysts polled by FactSet expect non-GAAP EPS of $4.92 on revenue of $2.83 billion.

Shares of the company were up nearly 5% in recent premarket activity.